Dvax earnings estimate

Author: tqbe

August undefined, 2024

WebApr 12, 2024 · Industry Drug Manufacturers - Specialty & Generic Investment Style Small Growth Day Range 9.73 – 9.86 Year Range 7.26 – 17.48 Market Cap 1.2520 Bil Volume / Avg 348,881.0 / 1.5 Mil Price / Sales... WebSee Dynavax Technologies Corporation (DVAX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Recap: Dynavax Technologies Q4 Earnings - Benzinga

WebOn Invalid Date, Dynavax Technologies (NASDAQ: DVAX) reported Q4 2024 earnings per share (EPS) of $0.53, up 35.37% year over year. Total Dynavax Technologies earnings for … WebMar 17, 2024 · Dynavax Technologies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 … culichinews

Dynavax Technologies (DVAX) Beats Q3 Earnings and Revenue Estimates

WebFeb 25, 2024 · Analysts estimate that Dynavax Technologies will report an earnings per share (EPS) of $0.69. Dynavax Technologies (NASDAQ:DVAX) is set to give its latest quarterly earnings report on Monday, 2024 ... WebNov 3, 2024 · Dynavax Technologies (DVAX) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to … Web2 days ago · Brian Evans. CNBC. Stocks jumped Thursday as traders cheered another report pointing to cooling U.S. inflation. The S&P 500 climbed 1.33% to 4,146.22 for its highest close since February. The ... culichi munchies owner

DVAX Dynavax Technologies Corp. Analyst Estimates & Rating – …

DVAX Dynavax Technologies Corp. Financial Statements - WSJ

WebApr 11, 2024 · Dynavax Technologies (NASDAQ:DVAX - Get Rating) last issued its quarterly earnings data on Thursday, February 23rd. The biopharmaceutical company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.01). Dynavax Technologies had a return on equity of 65.26% and a net margin of 40.56%. WebNov 8, 2024 · The earnings estimate of $0.36 per share for the current quarter represents a change of -34.55% from the number reported a year ago. The Zacks Consensus Estimate for Dynavax Technologies has... culiau how to useWeb1 day ago · Price To Cash Flow is a widely used stock evaluation measure. Find the latest Price To Cash Flow for Dynavax Technologies (DVAX) culichi mexican seafood bar

"WebAug 4, 2024 · D ynavax Technologies (DVAX) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.27 per share a... " - Dvax earnings estimate

Dvax earnings estimate

DVAX Stock News DYNAVAX TECHNOLOGIES Stock Price …

WebDynavax Technologies Corp. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View DVAX financial statements in full. Dow Jones, a News … WebOct 30, 2024 · Dynavax Technologies (DVAX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. ... Earnings Whisper. Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming …

Did you know?

WebResearch & Ratings Dynavax Technologies Corp. Per-Share Earnings, Actuals and Estimates Quarterly Annual DVAX will report Q1 earnings on 05/10/2024 Analyst Range Consensus … WebFeb 28, 2024 · Dynavax Technologies missed estimated earnings by 20.29%, reporting an EPS of $0.55 versus an estimate of $0.69. Revenue was up $175.52 million from the same period last year. Past Earnings...

WebMay 5, 2024 · Dynavax Technologies (DVAX) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.24 per share. This compares to … WebNovavax Inc $7.59 NVAX3.41% Tonix Pharmaceuticals Holding Corp $0.59 TNXP3.96% Aurinia Pharmaceuticals Inc $9.98 AUPH1.67% CymaBay Therapeutics Inc $8.55 CBAY0.70% Ardelyx Inc $4.43 ARDX1.77%...

WebFind the latest Dynavax Technologies Corporatio (DVAX) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance WebApr 6, 2024 · DVAX Earnings Date and Information. Dynavax Technologies last announced its earnings data on February 23rd, 2024. The biopharmaceutical company reported $0.45 …

WebThe 6 analysts offering 12-month price forecasts for Dynavax Technologies Corp have a median target of 24.00, with a high estimate of 27.00 and a low estimate of 18.00. The median estimate...

WebAug 3, 2024 · The consensus EPS Estimate is $0.38 and the consensus Revenue Estimate is $150.99M (+186.1% Y/Y). Over the last 2 years, DVAX has beaten EPS estimates 50% of the time and has beaten revenue... culicchia hearing and balance centerWebAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX) and Blackmores Limited (OtherBLMMF) Feb. 28, 2024 at 10:50 a.m. ET on TipRanks.com Viatris' (VTRS) Q4 Earnings In-Line, Revenues... eastern time to mexico city time culichi and beer san antonio txWebDVAX Dynavax Technologies Corp. Analyst Estimates & Rating – WSJ Dynavax Technologies Corp. DVAX (U.S.: Nasdaq) View All companies AT CLOSE 4:00 PM EDT … culichis and beer coltonWebOct 28, 2024 · Zacks Consensus Estimate This biopharmaceutical company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of +133.3%.... culichis and beer colton menuWebDVAX Key Statistics Market cap 1.33B Price-Earnings ratio 5.31 Dividend yield — Average volume 1.01M High today $10.58 Low today $10.04 Open price $10.08 Volume 1.24M 52 Week high $17.48 52 Week low $7.26 DVAX News Simply Wall St 2d The 8.2% return this week takes Dynavax Technologies' shareholders three-year gains to 255% - Simply Wall St culicchia hearing and balanceWebOct 27, 2024 · The company’s surprise history has been excellent so far with its earnings beating estimates in each of the trailing four quarters, of the average being 91.67%. In the … culichis and beer